bibliographic resource 2038766 [br/2038766]
https://w3id.org/oc/corpus/br/2038766

is a
title
  • Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
publication date
  • 2014-01-01
contributor
format
identifier
part of